Apoptosis in cardiac disease

American Journal of Medicine

Volumn 107, Issue 6, 1999, Pages 606-620

  James, Thomas N ^a,b  

^a Division of Infectious Diseases   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; DISEASE COURSE; HEART DISEASE; HEART MUSCLE CONDUCTION SYSTEM; HEART RIGHT VENTRICLE; HISTOCHEMISTRY; HUMAN; LONG QT SYNDROME; MORPHOLOGY; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SUDDEN DEATH; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0032806358     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00308-3     Document Type: Article

References (64)

1. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis a basic biological phenomenon with wide-ranging implications in tissue kinetics . Br J Cancer. 26:1972;239-257.
2. Searle J., Kerr J.F.R., Bishop C.J. Necrosis and apoptosis distinct modes of cell death with fundamentally different significance . Pathol Ann. 17:1982;229-259.
3. Alles A., Alley K., Barrett J.C., et al. Apoptosis a general comment . FASEB J. 5:1991;2127-2128.
4. James T.N. Cardiac conduction system fetal and postnatal development . Am J Cardiol. 25:1970;213-226.
5. James T.N. Normal and abnormal consequences of apoptosis in the human heart from postnatal morphogenesis to paroxysmal arrhythmias . Circulation. 90:1994;556-573.
6. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
7. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3:1997;614-620.
8. Kim Y.-M., Bombeck C.A., Billiar T.R. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res. 84:1999;253-256.
9. James T.N., Marshall T.K. De Subitaneis Mortibus. XVIII. Persistent fetal dispersion of the atrioventricular node and His bundle within central fibrous body. Circulation. 53:1976;1026-1034.
10. Brechenmacher C., Fauchier J.-P., James T.N. Persistent fetal dispersion of the atrioventricular node. Association with the Wolff-Parkinson-White syndrome. Arch Intern Med. 140:1980;377-382.
11. Nugent E.W., Plauth W.H., Edwards J.E., Williams W.H. The pathology, pathophysiology, recognition, and treatment of congenital heart disease. Schlant R.C., Alexander R.W. Hurst's The Heart. 8th ed. 1994;1763 McGraw-Hill, New York.
12. Kajstura J., Mansukhani M., Cheng W., et al. Programmed cell death and expression of the protooncogene bcl-2 in myocytes during postnatal maturation of the heart. Exper Cell Res. 219:1995;110-121.
13. James T.N., Monto R.W. Pathology of the cardiac conduction system in thrombotic thrombocytopenic purpura. Ann Intern Med. 65:1966;37-43.
14. Ridolfi R.L., Hutchins G.M., Bell W.R. The heart and cardiac conduction system in thrombotic thrombocytopenic purpura. Ann Intern Med. 91:1979;357-363.
15. Baroldi G., Manion W.C. Microcirculatory disturbances and human myocardial infarction. Am Heart J. 74:1967;173-178.
16. James T.N., Alperin J.B. Apoptotic myocardial degeneration in thrombotic thrombocytopenic purpura. Apoptosis. 2:1997;384-394.
17. Kajstura J., Cheng W., Reiss K., et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Investig. 74:1996;86-107.
18. James T.N. The variable morphological coexistence of apoptosis and necrosis in human myocardial infarction significance for understanding its pathogenesis, clinical course, diagnosis and prognosis . Cor Artery Dis. 9:1998;291-307.
19. Haider A.W., Andreotti F., Thompson G.R., et al. Serum lipoprotein(a) level is related to thrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction. Circulation. 94:1996;2072-2076.
20. LaDue J.S., Nydick I., Ruegsegger P. The effect of acute and chronic ischemia on enzymes of the myocardium. James T.N., Keyes J.W. Etiology of Myocardial Infarction. 1963;207-223 Little, Brown and Company, Boston.
21. Zimmerman J., Fromm R., Meyer D., et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation. 99:1999;1671-1677.
22. Starr I., Jeffers W.A., Meade R.H. The absence of conspicuous increments of venous pressure after severe damage to the right ventricle of the dog, with a discussion of the relation between clinical congestive failure and heart disease. Am Heart J. 26:1943;291-301.
23. James T.N. Anatomy of the crista supraventricularis its importance for understanding right ventricular function, right ventricular infarction and related conditions . J Am Coll Cardiol. 6:1985;1083-1095.
24. Uhl H.S.M. Uhl's anomaly revisited. Circulation. 93:1996;1483-1484.
25. James T.N., Nichols M.M., Sapire D.W., et al. Complete heart block and fatal right ventricular failure in an infant. A clinicopathologic conference describing massive apoptosis selectively destroying the entire right ventricle and the His bundle in an infant with complete heart block significance for understanding the pathogenesis of Uhl's anomaly and arrhythmogenic right ventricular dysplasia . Circulation. 93:1996;1588-1600.
26. Mallat Z., Tedgui A., Fontaliran F., et al. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. NEJM. 335:1996;1190-1196.
27. Valente M., Calabrese F., Thiene G., et al. In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am J Pathol. 152:1998;479-484.
28. Brink A.J., Torrington M. Progressive familial heart block - two types. South African Med. J. 52:1977;53-59.
29. Brink P.A., Ferreira A., Moolman J.C., et al. Gene for progressive familial heart block type I maps to chromosome 19q13. Circulation. 91:1995;1633-1640.
30. James T.N., St. Martin E., Willis P.W., Lohr T.O. Apoptosis as a possible cause of gradual development of complete heart block and fatal arrhythmias associated with absence of the AV node, the sinus node and the internodal pathways. Circulation. 93:1996;1424-1438.
31. James T.N. The connecting pathways between the sinus node and AV node and between the right and left atrium in the human heart. Am Heart J. 66:1963;498-508.
32. 3. A marker for sudden death in patients without demonstrable structural heart disease. Circulation. 97:1998;457-460.
33. Jervell A., Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden death. Am Heart J. 54:1957;59-68.
34. Romano C., Gemme G., Pongiglione R. Aritmie cardiache rare dell'eta' pediatrica. II. Accessi sincopali per fibrillaziono ventricolare parossistica. (Presentazione del primo case della letteratura pediatrica italiana). Clinica Pediatrica. 45:1963;656-683.
35. Ward O.C. A new familial cardiac syndrome in children. J Irish Med Assoc. 54:1964;103-106.
36. Levine S.A., Woodworth C.R. Congenital deaf-mutism, prolonged QT interval, syncopal attacks and sudden death. NEJM. 259:1958;412-417.
37. Fraser G.R., Froggatt P., James T.N. Congenital deafness associated with electrocardiographic abnormalities, fainting attacks and sudden death. A recessive syndrome. Quar J Med. 33:1964;361-385.
38. Bokeriya L.A., Belokon' N.A., Buziashvili IuI, et al. The current approach to surgical treatment of the Jervell-Lange-Nielsen syndrome. Kardiologiia. 28:1988;105-106.
39. Crawford M.H., Karliner J.S., O'Rourke R.A., Friedman W.F. Prolonged Q-T interval syndrome. Successful treatment with combined ventricular pacing and propranolol. Chest. 68:1975;369-373.
40. Eldar M., Griffin J.C., Van Hare G.F., et al. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long-QT syndrome. J Am Coll Cardiol. 20:1992;830-837.
41. Furman S. Prevalence, circumstances, mechanisms, and risk stratification of sudden cardiac death in artificial ventricular pacing. Circulation. 85:1992;843-844.
42. Zehender M., Buchner C., Meinertz T., Just H. Prevalence, circumstances, mechanisms, and risk stratification of sudden cardiac death in unipolar single-chamber ventricular pacing. Circulation. 85:1992;596-605.
43. Pavlovich E.P., Vikhert A.M., Bokeriya L.A., Kruglyakov I.V. Ultrastructure of the sinoauricular region of the heart in long QT syndrome. Arkhiv Patologii. 51:1989;25-32.
44. James T.N., Terasaki F., Pavlovich E.R., Vikhert A.M. Apoptosis and pleomorphic micromitochondriosis in the sinus nodes surgically excised from five patients with the long QT syndrome. J Lab Clin Med. 122:1993;309-323.
45. James T.N. Long reflections on the QT interval. The Sixth Annual Gordon K. Moe Lecture. J Cardiovasc Electrophysiol. 7:1996;738-759.
46. James T.N., Froggatt P., Atkinson W.J., et al. De Subitaneis Mortibus. XXX. Observations on the pathophysiology of the long QT syndromes with special reference to the neuropathology of the heart. Circulation. 57:1978;1221-1231.
47. James T.N. Congenital deafness and cardiac arrhythmias. Am J Cardiol. 19:1967;627-643.
48. Mathews E.C., Blount A.W., Townsend J.I. Q-T prolongation and ventricular arrhythmias, with and without deafness, in the same family. Am J Cardiol. 29:1972;702-711.
49. Neyroud N., Tesson F., Denjoy I., et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nature Genet. 15:1997;186-189.
50. Splawski I., Timothy K.W., Vincent G.M., et al. Molecular basis of the long-QT syndrome associated with deafness. NEJM. 336:1997;1562-1567.
51. Ackerman M.J., Clapham D.E. Ion channels - basic science and clinical disease. NEJM. 336:1997;1575-1586.
52. James T.N. Apoptosis in congenital heart disease. Cor Artery Dis. 8:1997;599-616.
53. Benson C.J., Eckert S.P., McCleskey E.W. Acid-evoked currents in cardiac sensory neurons. A possible mediator of myocardial ischemic sensation. Circ Res. 84:1999;921-928.
54. James T.N., Rossi L., Hageman G.R. On the pathogenesis of angina pectoris and its silence. Transact Am Clin Climatolog Assoc. 100:1988;81-99.
55. James T.N. Chance and sudden death. J Am Coll Cardiol. 1:1983;164-183.
56. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia a delay of lethal cell injury in ischemic myocardium . Circulation. 74:1986;1124-1136.
57. Przyklenk K., Kloner R.A. Ischemic preconditioning exploring the paradox . Prog Cardiovasc Dis. 40:1998;517-547.
58. Harmon B.V., Takano Y.S., Winterford C.M., Gobé G.C. The role of apoptosis in the response of cells and tumours to mild hyperthermia. Int J Radiat Biol. 59:1991;489-501.
59. Lennon S.V., Martin S.J., Cotter T.G. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Proliferation. 24:1991;203-214.
60. Schumer M., Colombel M.C., Sawczuk I.S., et al. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol. 140:1992;831-838.
61. Gottlieb R.A., Burleson K.O., Kloner R.A., et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Investig. 94:1994;1621-1628.
62. Gottlieb R.A., Gruol D.L., Zhu J.Y., Engler R.L. Preconditioning in rabbit cardiomyocytes. Role of pH, vacuolar proton ATPase, and apoptosis. J Clin Investig. 97:1996;2391-2398.
63. Piot C.A., Padmanaban D., Ursell P.C., et al. Ischemic preconditioning decreases apoptosis in rat hearts in vivo. Circulation. 96:1997;1598-1604.
64. Laskey W.K. Beneficial impact of preconditioning during PTCA on creatine kinase release. Circulation. 99:1999;2085-2089.